Onesource Specialty Pharma Q4 Results
- BSE: 544292
- NSE: ONESOURCE
- ISIN: INE013P01021
- Sector: Biotechnology & Drugs
BSE
1,708.30
-29.85 (-1.72%)
-29.85 (-1.72%)Volume7.54 K
Updated: Tue 9 Jun, 2026 | 11:53:07
NSE
1,710.40-27.40 (-1.58%)
-27.40 (-1.58%)Volume88.57 K
Updated: Tue 9 Jun, 2026 | 11:40:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Incomeâ‚ą428.22 Cr.(0.53%)
- Operating Profitâ‚ą20.13 Cr.(-82.22%)
- Profit After Taxâ‚ą4.60 Cr.(-95.37%)
- Operating Margin4.70%(-82.32%)
Note: Comparison is on YoY basis
Quarterly - Onesource Specialty Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 408.09 | 349.75 | 16.68% | 88.42 | 30.49% |
| Depreciation/ Amortization | 71.83 | 69.64 | 3.14% | 19.53 | 4.87% |
| Operating Income | 20.13 | -59.40 | 0.00% | -15.28 | -82.22% |
| Net Income | 4.60 | -88.70 | 0.00% | -40.17 | -95.33% |
| Other Operating Expenses Total | 127.29 | 114.46 | 11.21% | 29.70 | 54.73% |
| Net Income Before Taxes | -0.29 | -93.01 | -99.69% | -40.17 | 0.00% |
| Total Revenue | 428.22 | 290.34 | 47.49% | 73.14 | 0.53% |
| Selling/ General/ Admin Expenses Total | 62.74 | 64.19 | -2.26% | 20.44 | 22.88% |
| Diluted Normalized EPS | 0.40 | -7.34 | 0.00% | -1.03 | -95.41% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.